Summary

Global Blood Transfusion Diagnostics Market is valued approximately USD 3.7137 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 6.50 % over the forecast period 2021-2027. Blood Transfusion Diagnostics is test which is performed on blood and blood component before transfusing them to patient. Each blood unit is tested for blood group typing disease screening in order to prevent adverse reactions. The increasing in number of anemias, which require red blood cell transfusion for its treatment. For instance, according to WHO, anemia affected around 1.62 billion people across the world. Furthermore, increase in demand for blood and blood component is boosting the growth for the blood transfusion diagnostics market. For instance, International Society of Nephrology, there are more than 850 million people who are diagnosed with kidney diseases. Also, with the increase in awareness regarding blood safety from infectious disease and high demand of blood screening tests and other diagnostic tools would create opportunity for the market in the forecasted period. However, high costs associated with the test and instruments impedes the growth of the market over the forecast period of 2021-2027.

The key regions considered for the global Blood Transfusion Diagnostics market study includes Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is dominating region across the world in terms of market share owing to the high adoption of blood transfusion process. For instance, according to the data published by the National Centre for Biotechnology Information, in US, nearly 15 million blood units are transfused every year and approximately 85 million units are transfused worldwide. Whereas, Europe is anticipated to exhibit highest CAGR over the forecast period 2021-2027. Factors such as growing availability of CE-approved instrument assays for serological and Nucleic Acid Test (NAT) based method in the region are used which accelerate the growth of the market in the forecasted period.

Major market player included in this report are:
Grifols, S.A.
Immucor, Inc.
Bio-Rad Laboratories, Inc.
Ortho Clinical Diagnostics
F. Hoffmann-La Roche Ltd.
QUOTIONT
Merck KGaA
Abbott
BAG Healthcare GmbH
DiaSorin S.P.A.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Outlook:
Reagents & Kits
Instruments
Others
By Application Outlook:
Blood Grouping
Disease Screening
By End-Use Outlook:
Hospitals
Blood Banks
Diagnostic Laboratories
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027

Target Audience of the Global Blood Transfusion Diagnostics Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

ページTOPに戻る

Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Blood Transfusion Diagnostics Market, by Region, 2019-2027 (USD Billion)
1.2.2. Blood Transfusion Diagnostics Market, by Product Outlook, 2019-2027 (USD Billion)
1.2.3. Blood Transfusion Diagnostics Market, by Application Outlook, 2019-2027 (USD Billion)
1.2.4. Blood Transfusion Diagnostics Market, by End-Use Outlook, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Blood Transfusion Diagnostics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Blood Transfusion Diagnostics Market Dynamics
3.1. Blood Transfusion Diagnostics Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increasing number of patients of anaemia
3.1.1.2. Increasing demand for blood and blood component
3.1.2. Market Challenges
3.1.2.1. High cost of test
3.1.3. Market Opportunities
3.1.3.1. Increasing awareness regarding blood safety
Chapter 4. Global Blood Transfusion Diagnostics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Blood Transfusion Diagnostics Market, by Product Outlook
6.1. Market Snapshot
6.2. Global Blood Transfusion Diagnostics Market by Product Outlook, Performance - Potential Analysis
6.3. Global Blood Transfusion Diagnostics Market Estimates & Forecasts by Product Outlook 2018-2027 (USD Billion)
6.4. Blood Transfusion Diagnostics Market, Sub Segment Analysis
6.4.1. Reagents & Kits
6.4.2. Instruments
6.4.3. Others
Chapter 7. Global Blood Transfusion Diagnostics Market, by Application Outlook
7.1. Market Snapshot
7.2. Global Blood Transfusion Diagnostics Market by Application Outlook, Performance - Potential Analysis
7.3. Global Blood Transfusion Diagnostics Market Estimates & Forecasts by Application Outlook 2018-2027 (USD Billion)
7.4. Blood Transfusion Diagnostics Market, Sub Segment Analysis
7.4.1. Blood Grouping
7.4.2. Disease Screening
Chapter 8. Global Blood Transfusion Diagnostics Market, by End-Use Outlook
8.1. Market Snapshot
8.2. Global Blood Transfusion Diagnostics Market by End-Use Outlook, Performance - Potential Analysis
8.3. Global Blood Transfusion Diagnostics Market Estimates & Forecasts by End-use Outlook 2018-2027 (USD Billion)
8.4. Blood Transfusion Diagnostics Market, Sub Segment Analysis
8.4.1. Hospitals
8.4.2. Blood Banks
8.4.3. Diagnostic Laboratories
8.4.4. Others
Chapter 9. Global Blood Transfusion Diagnostics Market, Regional Analysis
9.1. Blood Transfusion Diagnostics Market, Regional Market Snapshot
9.2. North America Blood Transfusion Diagnostics Market
9.2.1. U.S. Blood Transfusion Diagnostics Market
9.2.1.1. Product Outlook breakdown estimates & forecasts, 2018-2027
9.2.1.2. Application Outlook breakdown estimates & forecasts, 2018-2027
9.2.1.3. End-Use Outlook breakdown estimates & forecasts, 2018-2027
9.2.2. Canada Blood Transfusion Diagnostics Market
9.3. Europe Blood Transfusion Diagnostics Market Snapshot
9.3.1. U.K. Blood Transfusion Diagnostics Market
9.3.2. Germany Blood Transfusion Diagnostics Market
9.3.3. France Blood Transfusion Diagnostics Market
9.3.4. Spain Blood Transfusion Diagnostics Market
9.3.5. Italy Blood Transfusion Diagnostics Market
9.3.6. Rest of Europe Blood Transfusion Diagnostics Market
9.4. Asia-Pacific Blood Transfusion Diagnostics Market Snapshot
9.4.1. China Blood Transfusion Diagnostics Market
9.4.2. India Blood Transfusion Diagnostics Market
9.4.3. Japan Blood Transfusion Diagnostics Market
9.4.4. Australia Blood Transfusion Diagnostics Market
9.4.5. South Korea Blood Transfusion Diagnostics Market
9.4.6. Rest of Asia Pacific Blood Transfusion Diagnostics Market
9.5. Latin America Blood Transfusion Diagnostics Market Snapshot
9.5.1. Brazil Blood Transfusion Diagnostics Market
9.5.2. Mexico Blood Transfusion Diagnostics Market
9.6. Rest of The World Blood Transfusion Diagnostics Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Grifols, S.A.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Immucor, Inc.
10.2.3. Bio-Rad Laboratories, Inc.
10.2.4. Ortho Clinical Diagnostics
10.2.5. F. Hoffmann-La Roche Ltd.
10.2.6. QUOTIONT
10.2.7. Merck KGaA
10.2.8. Abbott
10.2.9. BAG Healthcare GmbH
10.2.10. DiaSorin S.P.A.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption